RecruitingPhase 2NCT06295952
A Study of Pasireotide in People With Prolactinoma
Studying Pituitary tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Eliza Geer, MD, M.DMemorial Sloan Kettering Cancer Center
- Intervention
- Pasireotide(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (7)
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Collaborators
RECORDATI GROUP
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06295952 on ClinicalTrials.govOther trials for Pituitary tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07463235Safety and Potency of a High Cabergoline Dosage in MicroprolactinomasUniversity of Sao Paulo General Hospital
- ENROLLING BY INVITATIONEARLY PHASE1NCT07254104Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary TumorsPeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGNCT06936813The PROMISE SurveyUniversity Hospital, Basel, Switzerland
- RECRUITINGPHASE2NCT06471829A Trial of Lu AG13909 in Adult Participants With Cushing's DiseaseH. Lundbeck A/S
- RECRUITINGNANCT06472505Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid LeakageNational Taiwan University Hospital
- RECRUITINGNCT06015802Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine TumorsSun Yat-sen University
- RECRUITINGNANCT05659524Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary SurgeryLori Wood
- RECRUITINGNCT00599092Pituitary Tumor Surveillance: Pathogenic CorrelationCedars-Sinai Medical Center